Class II recall: American Regent, Inc.: Multrys (Trace Elements Injection 4, USP), For intravenous infusion, packaged in
American Regent, Inc. has issued a Class II recall of Multrys (Trace Elements Injection 4, USP), an intravenous infusion product packaged in 1 mL and 25x1 mL single-dose vials (NDC 0517-9302-01 and 0517-9302-25). According to the recall notice, affected units were found to contain particulate matter identified as hair, glass, and/or paraformaldehyde.
Most relevant for: Patients receiving intravenous trace element supplementation, particularly those in hospital settings or receiving parenteral nutrition support
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More internal medicine updates
- Long-acting injectable noninferior to oral HIV therapy in adherence trialOct 15, 2026
- Ponatinib-Blinatumomab Beats Imatinib-Chemotherapy in Ph-Positive ALL TrialOct 15, 2026
- Isoflurane sedation does not lower mortality in hypoxemic respiratory failureOct 14, 2026
- Trial finds higher mortality with intermittent vs continuous renal-replacement therapyOct 14, 2026
- No Overall Rise in Birth Defects With Early Benzodiazepine UseOct 13, 2026